Long distance runners and body-builders exhibit elevated plasma levels of lipoprotein(a).
A one-point cross-sectional study of 20 sedentary individuals, 20 low-aerobic athletes (body-builders), and 20 high-aerobic athletes (long distance, endurance runners) was conducted in Mexico City, Mexico to determine the influence of these diverse life-styles on the plasma levels of Lp(a). Only non-obese male subjects, aged 23-33, who were nonsmokers, non-alcoholics, and had never used anabolic steroids were included in this study. Blood samples were drawn 24 h following the last period of physical activity, and after a 12-14-h fast-period and a 15-min sitting-rest. Plasma levels of Lp(a) and other parameters, including postheparin lipoprotein lipase (LPL) and hepatic lipase (HL) activities, triglycerides (TG), total cholesterol (TC), LDL cholesterol (LDL-C), and HDL cholesterol (HDL-C), as well as % body fat and muscle mass, and maximum aerobic capacity (VO2max) were measured to determine possible correlations with Lp(a) and to serve as convenient internal standards. Mean Lp(a) concentrations were significantly higher in the runners (52 +/- 19 mg/dl) than in the body-builders (40 +/- 6.4 mg/dl, P < 0.05) and the sedentary subjects (24 +/- 5 mg/dl, P < 0.001). Positive correlations between Lp(a) and Vo2max (P < 0.001), HDL-C (P < 0.005) and HDL2-C subfraction (P < 0.005), and a negative correlation with TG were determined. Agglomerative cluster methods suggested three close-distance clusters and a fourth cluster which is composed of four runners who exhibited low LDL-C/HDL-C and high LPL/HL ratios, high mean Lp(a), HDL2-C, and Vo2max levels, but low TG levels. These data show that some individuals who maintain a life-style of very high level physical exertion may have remarkably elevated plasma Lp(a) concentrations. The highly increased concentrations of Lp(a) in high exercise athletes may represent a normal metabolic response to repeated small tissue injuries resulting from frequent and prolonged large muscle movement.
Cardoso
G C
GC
Department of Endocrinology, National Institute of Cardiology Ignacio Chavez, Mexico City, Mexico.
Posadas
C
C
Orvanaños
O O
OO
Peniche
C
C
Zamora
J
J
Aguilar
R
R
Holguin
J A
JA
Raynaud
A S
AS
Morrisett
J D
JD
Guevara
J
J
D000328:Adult; D002784:Cholesterol / Q000097:blood; D016000:Cluster Analysis; D004032:Diet; D006801:Humans; D008049:Lipase / Q000097:blood; D008055:Lipids / Q000097:blood; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D009132:Muscles / Q000293:injuries / Q000378:metabolism; D010807:Physical Endurance / Q000502:physiology; D012420:Running / Q000293:injuries / Q000502:physiology*; D014280:Triglycerides / Q000097:blood; D014891:Weight Lifting / Q000293:injuries / Q000502:physiology*
D008055:Lipids; D017270:Lipoprotein(a); D014280:Triglycerides; D002784:Cholesterol; D008049:Lipase